Vogenx (VOGX)
Vogenx, Inc. operates as a clinical-stage drug development company that develops therapeutics for metabolic including post-bariatric hypoglycemia, or PBH, and g...
- Open
- 14.340
- High
- 16.650
- Low
- 13.500
- Prev. Close
- 14.090
- Volume
- 37.23K
- Turnover
- 552.86K
- Avg Price
- 14.849
- Bid/Ask Ratio
- --
- Amplitude
- 22.36%
- 52wk High
- 16.650
- Volume Ratio
- 0.00
- Turnover Ratio
- 0.42%
